Although ILCs provide a rapid source of IL-22 that is essential for early protection of epithelial barrier function upon inflammatory insult, CD4+ T cells become the dominant source of IL-22 in the intestinal lamina propria (LP) during chronic intestinal inflammation. The gene discussed is IL22; the disease is inflammatory response.